Home › Agilent Technologies Collaborating With Weill Cornell Medical College To Advance Research In ALS
 

Keywords :   


Agilent Technologies Collaborating With Weill Cornell Medical College To Advance Research In ALS

2015-08-31 07:45:39| chemicalonline Home Page

Agilent Technologies Inc. recently announced it is collaborating with Dr. Steven Gross, a faculty member in the Department of Pharmacology at Weill Cornell Medical College, in New York, N.Y., to advance research in amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease

Tags: als research college medical

Category:Chemicals

Latest from this category

All news
16.05BASF Expands Biomass Balance Portfolio for Selected Chemical Intermediates
16.05AkzoNobels Como Site Achieves Highest Automotive Industry Quality Certification
15.05Sherwin-Williams Packaging Coatings Expands Non-BPA Coatings Production in Europe
15.05KANSAI HELIOS Completes Acquisition of WEILBURGER Coatings
15.05Dunn-Edwards Reveals New Multifamily Color Collection
15.05Axalta Hosting Strategy Day; Outlining Three-Year Plan for Accelerating Performance
15.05BASF Paves the Way for Young Painters at WorldSkills Finals Lyon 2024
14.05PPG Exhibits at The Battery Show
Chemicals »
17.05More people seek help for debts as fee scrapped
17.05Hunt hints at another National Insurance tax cut
17.05Alan Bates rejects second Post Office compensation offer
17.05Severn Trent boss defends multi-million pay packet
17.05Coptis Marks 25th Anniversary
17.05Farm Progress America, May 17, 2024
17.05Farm Progress America, May 17, 2024
17.05China pours billions into crisis-hit property market
More »